Literature DB >> 26188381

Progesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration.

Ebony Washington Remus1, Iqbal Sayeed1, Soonmi Won1, Alicia N Lyle2, Donald G Stein3.   

Abstract

The neuroprotective effects of progesterone after ischemic stroke have been established, but the role of progesterone in promoting cerebrovascular repair remains under-explored. Male Sprague-Dawley rats underwent transient middle cerebral artery occlusion (tMCAO) for 90 min followed by reperfusion for 3 days. Progesterone (8 mg/kg/day) was administered intraperitoneally at 1h after initial occlusion followed by subcutaneous injections at 6, 24 and 48 h post-occlusion. Rats were euthanized after 72 h and brain endothelial cell density and macrophage infiltration were evaluated within the cerebral cortex. We also assessed progesterone's ability to induce macrophage migration toward hypoxic/reoxygenated cultured endothelial cells. We found that progesterone treatment post-tMCAO protects ischemic endothelial cells from macrophage infiltration. We further demonstrate that infiltration of monocytes/macrophages can be induced by potent chemotactic factors such as monocyte chemoattractant protein-1 (MCP-1) and the chemokine ligand 1 (CXCL1), secreted by hypoxic/reoxygenated endothelial cells. Progesterone blunts secretion of MCP-1 and CXCL1 from endothelial cells after hypoxia/reoxygenation injury and decreases leukocyte infiltration. The treatment protects ischemic endothelial cells from macrophage infiltration and thus preserves vascularization after ischemic injury.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain ischemia; Cerebrovascular repair; Endothelial cells; Macrophage infiltration; Progesterone

Mesh:

Substances:

Year:  2015        PMID: 26188381      PMCID: PMC4586408          DOI: 10.1016/j.expneurol.2015.07.010

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  37 in total

Review 1.  Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.

Authors:  Stephan Segerer; Peter J Nelson; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

2.  Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.

Authors:  J C Grotta; W S Burgin; A El-Mitwalli; M Long; M Campbell; L B Morgenstern; M Malkoff; A V Alexandrov
Journal:  Arch Neurol       Date:  2001-12

3.  Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine.

Authors:  B Chandrasekar; J B Smith; G L Freeman
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

4.  Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB.

Authors:  Fion L Sung; Tong Y Zhu; Kathy K W Au-Yeung; Yaw L Siow; Karmin O
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

Review 5.  The role of the chemokines in myocardial ischemia and reperfusion.

Authors:  Nikolaos G Frangogiannis
Journal:  Curr Vasc Pharmacol       Date:  2004-04       Impact factor: 2.719

6.  Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium.

Authors:  Y J Shyy; H J Hsieh; S Usami; S Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Alpha chemokines regulate direct lung ischemia-reperfusion injury.

Authors:  Alexander S Farivar; Baiya Krishnadasan; Babu V Naidu; Steven M Woolley; Edward D Verrier; Michael S Mulligan
Journal:  J Heart Lung Transplant       Date:  2004-05       Impact factor: 10.247

Review 8.  Macrophages and angiogenesis.

Authors:  C Sunderkötter; K Steinbrink; M Goebeler; R Bhardwaj; C Sorg
Journal:  J Leukoc Biol       Date:  1994-03       Impact factor: 4.962

9.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

10.  Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study.

Authors:  Bushra Wali; Tauheed Ishrat; Soonmi Won; Donald G Stein; Iqbal Sayeed
Journal:  Brain       Date:  2013-12-26       Impact factor: 13.501

View more
  8 in total

1.  CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma.

Authors:  Guang-Tao Yu; Lin-Lin Bu; Yu-Yue Zhao; Liang Mao; Wei-Wei Deng; Tian-Fu Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

2.  LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma.

Authors:  Wei-Wei Deng; Liang Mao; Guang-Tao Yu; Lin-Lin Bu; Si-Rui Ma; Bing Liu; J Silvio Gutkind; Ashok B Kulkarni; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2016-10-07       Impact factor: 8.110

Review 3.  Neural stem cell therapy for stroke: A multimechanistic approach to restoring neurological function.

Authors:  Emily W Baker; Holly A Kinder; Franklin D West
Journal:  Brain Behav       Date:  2019-02-12       Impact factor: 3.405

4.  Identification of the key genes and immune infiltrating cells determined by sex differences in ischaemic stroke through co-expression network module.

Authors:  Haipeng Xu; Yanzhi Ge; Yang Liu; Yang Zheng; Rong Hu; Conglin Ren; Qianqian Liu
Journal:  IET Syst Biol       Date:  2021-11-18       Impact factor: 1.615

Review 5.  The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials.

Authors:  Huixia Geng; Luna Chen; Jing Tang; Yi'ang Chen; Lai Wang
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

6.  Parity History Determines a Systemic Inflammatory Response to Spread of Ovarian Cancer in Naturally Aged Mice.

Authors:  Ulises Urzua; Carlos Chacon; Luis Lizama; Sebastián Sarmiento; Pía Villalobos; Belén Kroxato; Katherine Marcelain; María-Julieta Gonzalez
Journal:  Aging Dis       Date:  2017-10-01       Impact factor: 6.745

7.  Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease.

Authors:  Nanae Ishida; Maki Saito; Sachiko Sato; Yu Tezuka; Atsushi Sanbe; Eiichi Taira; Masamichi Hirose
Journal:  Pharmacol Res Perspect       Date:  2021-10

8.  Serum progesterone and retinopathy in male patients with type 2 diabetes: A cross-sectional study.

Authors:  Shengnan Sun; Yahao Wang; Yue Zhou; Wenru Ma; Yajing Huang; Jianxia Hu; Yangang Wang
Journal:  J Diabetes Investig       Date:  2020-12-14       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.